In August of 2015, Turing Pharmaceuticals CEO Martin Shkreli raised the price of Daraprim from $13.50 per tablet to $750 per tablet; since then 17-year-old high school students from Sydney Grammar have been able to replicate the active ingredient in the drug for only $20.
Home Corporate